Jasper Therapeutics is going ahead with its SPAC merger despite a $93M funding shortfall

Jasper's blank-check partner promised it would give the biotechnology startup $100 million when they merged. Instead, it's only going to directly give Jasper an estimated $7 million.

Click to view original post